GRIFOLS SA INH. A EO-,25/ ES0171996087 /
2024-05-31 7:31:31 PM | Chg. +0.058 | Volume | Bid7:40:23 PM | Ask7:40:23 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.230EUR | +0.63% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 7.69 bill.EUR | - | 103.64 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...